Advanced in Upper Tract Urothelial Carcinoma (UTUC)

Mathieu Roumiguie

CHU Rennes
Rennes, FR 
Advanced in Upper Tract Urothelial Carcinoma (UTUC)
CHU Rennes
Rennes, FR 
OverviewLocationsClinical Research

Overview

Mathieu Roumiguie practices in Rennes, France. Mr. Roumiguie is rated as an Advanced expert by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Bladder Cancer, Urothelial Cancer, Prostate Cancer, Cystectomy, and Nephrectomy.

His clinical research consists of co-authoring 261 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Upper Tract Urothelial Carcinoma (UTUC).

Gender
Male

Locations

CHU Rennes
Rennes, France
Other Locations
CHU Toulouse
Toulouse, 31000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of the Xpert® Bladder Cancer Monitor Assay Compared to Cystoscopy for the Follow-up of Patients With History of Low or Intermediate Risk Non-muscle-invasive Bladder Cancer (NMIBC): an Observational Prospective International Multicenter Study
Evaluation of the Xpert® Bladder Cancer Monitor Assay Compared to Cystoscopy for the Follow-up of Patients With History of Low or Intermediate Risk Non-muscle-invasive Bladder Cancer (NMIBC): an Observational Prospective International Multicenter Study
Enrollment Status: Completed
Publish Date: February 13, 2023
Intervention Type: Diagnostic test
Prospective Multicentric Evaluation of a Bladder Preservation Strategy Using a Combination of Neoadjuvant Chemotherapy and Optimal Bladder Transurethral Resection in Patients With a Urothelial Carcinoma
Prospective Multicentric Evaluation of a Bladder Preservation Strategy Using a Combination of Neoadjuvant Chemotherapy and Optimal Bladder Transurethral Resection in Patients With a Urothelial Carcinoma
Enrollment Status: Terminated
Publish Date: December 30, 2021
Intervention Type: Drug
Study Drug: Optimal TURB
Study Phase: Phase 2
View 1 Less Clinical Trial

261 Total Publications

Temporal trends and clinical determinants of urinary diversion after radical cystectomy.
Temporal trends and clinical determinants of urinary diversion after radical cystectomy.
Journal: BJU international
Published: October 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Roumiguie's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile